A discussion of the changing medtech markets and how companies can remain cognizant of potentially disruptive changes in their business and industry for future success in their product portfolios, services and relationships.
The outlook for 2020 and beyond is positive, but medical device companies must continue to evolve their technologies and partnerships to keep the attention of investors.
This two-part virtual workshop will guide participants through the process of how to write effective documents.
A more comprehensive management approach is needed to tackle the rising threat of diabetes in the region.
A look at IP litigation in 2019 and the year ahead, and some advice on how medical device companies can safeguard their intellectual property.
How will you make your company more attractive to investors?
The hot issues are related to compliance, EU MDR and recalls.
Medtech companies must account for a more complex web of influencers on purchasing.
Eighty medtech transactions in Europe came in at a value of approximately $627.5 million.
Peter Micca of Deloitte discusses the changes that are happening within the healthcare ecosystem as a whole.